ArticleArchives of ophthalmology (Chicago, Ill. : 1960)2009
Glaucoma and reading speed: the Salisbury Eye Evaluation project.
Article in Archives of ophthalmology (Chicago, Ill. : 1960), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04736264 (Malay Glaucoma Eye Study II), which is not on this map. Cited by 62 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Malay Glaucoma Eye Study II: Elucidating Navigation, Mobility and Reading Ability to Improve Quality of Life and Progression of Primary Glaucoma
Who cites it
62 citing papers in PubMed, 147 citations in OpenAlex.
- Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.The British journal of ophthalmology · 2018Trial
- Binocular glaucomatous visual field loss and its impact on visual exploration--a supermarket study.PloS one · 2014Trial
- Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.Archives of ophthalmology (Chicago, Ill. : 1960) · 2012Trial
- Visual Field Loss and Self-Reported Driving Restriction in Glaucoma.Vision (Basel, Switzerland) · 2026Article
- Eye-tracking reading patterns across different interventions in glaucoma patients versus controls.Scientific reports · 2026Article
- Evaluation of reading performance in eyes simulated with different visual acuity and visual field impairment.BMC ophthalmology · 2026Article
- Eye-Tracking Reading Patterns as Correlates of Clinical Measures in Glaucoma.Ophthalmic research · 2026Article
- Differential Impact of Central and Global Visual Field Progression on Quality of Life in Glaucoma.American journal of ophthalmology · 2025Article
- Assessment of silent reading ability among glaucoma patients using an eye tracking system with horizontally scrolling text.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025Article
- Impact of Glaucomatous Ganglion Cell Damage on Central Visual Function.Annual review of vision science · 2024Review
- A Model of Progression to Help Identify Macular Damage Due to Glaucoma.Investigative ophthalmology & visual science · 2023Article
- Altered Eye Movements During Reading With Simulated Central and Peripheral Visual Field Defects.Investigative ophthalmology & visual science · 2023Article
- Quality of life in glaucoma.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023Review
- Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma.American journal of ophthalmology · 2023Article
- Approaching rehabilitation in patients with advanced glaucoma.Eye (London, England) · 2023Review
- Article
- Border tissue morphology is associated with the pattern of visual field progression in open-angle glaucoma.Scientific reports · 2022Article
- Foveal crowding appears to be robust to normal aging and glaucoma unlike parafoveal and peripheral crowding.Journal of vision · 2022Article
- Visual function tests for glaucoma practice - What is relevant?Indian journal of ophthalmology · 2022Review
- Eye Movement Abnormalities in Glaucoma Patients: A Review.Eye and brain · 2022Review
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
objectiveTo determine if, and at what point, glaucoma affects spoken reading speed.
methodsData were collected from the Salisbury Eye Evaluation, a population-based evaluation of visual function and disability in the elderly population. Nonscrolling text was displayed on a screen and the rate words were read aloud was measured. Subjects reading slower than 90 words/min were defined as having impairment. Glaucoma status was determined using optic disc appearance and visual field testing.
resultsOne thousand one hundred fifty-four subjects completed evaluations of spoken reading speed and glaucoma status. Univariate analysis demonstrated reading impairment in 16.0% of subjects without glaucoma, 21.1% of subjects with unilateral glaucoma (P = .25), and 28.4% of subjects with bilateral glaucoma (P = .006). Multivariable regression demonstrated nonsignificant increases in the odds of reading impairment for subjects with unilateral (odds ratio, [OR], 1.13; P = .69) and bilateral glaucoma (OR, 1.25; P = .43), though subjects with bilateral glaucoma in the highest quartile of better-eye visual field loss read slower (beta = -32 words/min; P = .01) and were more often reading impaired than controls without glaucoma (OR, 3.8; P = .04). Race, cognitive ability, education, and visual acuity were important predictors of reading impairment.
conclusionsHigh rates of spoken reading impairment were found throughout this elderly sample. Glaucoma was associated with slower reading and increased reading impairment with advanced bilateral field loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.